Navigation Links
Schering-Plough CEO Calls for Four-Pronged Approach to Improving Current Health Care Environment
Date:11/2/2007

ORLANDO, Fla., Nov. 2 /PRNewswire-FirstCall/ -- Addressing more than 100 cardiologists and other medical experts from 24 countries, Fred Hassan, Schering-Plough chairman and CEO, set out four critical priorities for improving the current health care environment. Hassan spoke today at Schering-Plough's fourth annual Cardiovascular Summit in advance of the American Heart Association's annual Scientific Sessions 2007.

In his speech, Hassan emphasized the potential for innovations to achieve major medical progress and improved treatment outcomes. He pointed to a study published in The New England Journal of Medicine (June 7, 2007 issue) that explored the reasons behind a dramatic decrease in U.S. deaths from cardiovascular disease between 1980-2000.

Hassan also reviewed the progress of Schering-Plough's transformation, its continuing investment in R&D and the promise of its planned combination with Organon BioSciences N.V.

Addressing the broader health care environment, Hassan identified four critical areas of opportunity for improvement:

-- First, transform the quality of care;

-- Second, transform biopharma's innovation engines;

-- Third, support a strong U.S. Food and Drug Administration; and,

-- Fourth, improve access and affordability for patients.

Hassan's speech (as prepared for delivery) is available via the following link: http://www.schering-plough.com/pdf/HassanCVSummitspeech11-2-07.pdf

Schering-Plough is a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough's vision is to earn the trust of the physicians, patients and customers served by its approximately 33,500 people around the world. The company is based in Kenilworth, N.J., and its Web site is http://www.schering-plough.com.


'/>"/>
SOURCE Schering-Plough
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Asmanex Twisthaler launched by Schering-Plough for treatment of asthma
2. Calls to combat deafness after chemotherapy
3. WHO Calls For Greater Emphasis On Combating AIDS
4. PCT Calls Upon Doctor To Delay Surgeries
5. UN Calls For More Funds For Earthquake Affected
6. MP Calls For Ban On Aspartame
7. Scientist Calls Upon Media To Retract His Work
8. CMHA Calls For Better Trained Police For Dealing With The Mentally Ill
9. US Government Calls For Better Drug Supplies
10. Phone Calls Lend Vital Support to Moms of Mentally Ill Children
11. Report Calls For Better Implementation Of Last Wishes of Terminally Ill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... recently received the CE Certificate of Conformity for the Smart System® 20/20. CE ... exceed the highest industry standards and specifications such as ANSI, ISO and proven ...
(Date:3/27/2017)... , ... March 27, 2017 , ... ... comprehensive weight management program at Women’s Excellence will help patients lose weight and ... physical exam. The specialists at Women's Excellence will measure BMI, body fat ...
(Date:3/27/2017)... ... March 27, 2017 , ... The ... supply chain professionals, will hold their first Northeast Regional AHVAP Meeting. For 2017, ... , “Increasingly, supply chain and value analysis professionals have a ‘seat at the ...
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium determination is consistently ... and require expert user knowledge. In a live webinar on April 11th and ... yet highly accurate, determination of sodium. , It has long been known that ...
(Date:3/27/2017)... Fla. (PRWEB) , ... March 27, 2017 , ... ... overdose deaths soared 167%,(1) with opioids alone responsible for over 33,000 of the ... McCarty has sponsored Assembly Bill (AB) 1512, which proposes a tax on prescription ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... NASHUA, N.H. , March 27, 2017 /PRNewswire/ ... image analysis, workflow solutions and radiation therapy for ... announced that PowerLook® Tomo Detection received Premarket Approval ... (FDA). PowerLook Tomo Detection is a first-of-its-kind, concurrent-read ... tomosynthesis and is the latest innovation available on ...
(Date:3/27/2017)... March 27, 2017 Cota Healthcare, ... value-based precision medicine, today announced the signing ... Pharmaceuticals Corporation to help improve clinical and ... As part of this agreement, which ... entered into January 2016, teams from across ...
(Date:3/27/2017)... -- Invivotek, LLC, a Genesis Biotechnology Group ® ... contract research organization (CRO), announced the completion of the ... research facility in Hamilton, New Jersey ... source to reduce costs and lessen the CRO facility,s ... Farm follows Invivotek,s recent expansion from a 19,712 square ...
Breaking Medicine Technology: